Spiro Lactide Copolymer Composition for ECM-Mimicking Biomaterials
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic biomaterials for tissue engineering lack reactive sites for presenting desirable biochemical stimuli and do not adequately mimic the natural extracellular matrix (ECM), limiting their effectiveness in tissue regeneration and repair.
Innovation Solution
Development of spiro lactide-based copolymers, including block, graft, and star-shaped copolymers, which incorporate a random copolymer of spiro[6-methyl-1,4-dioxane-2,5-dione-3,2′-bicyclo[2.2.1]hept[5]ene] with other monomers to provide reactive sites for biochemical cues and enhance mechanical properties, degradation rates, and bioactive molecule conjugation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional synthetic biomaterials are used, then manufacturing simplicity is maintained, but the materials lack reactive sites for biochemical stimuli and do not adequately mimic natural ECM
Solution Approach 1:
The patent employs copolymer composition, combining spiro lactide with other lactide monomers (DL-lactide, L-lactide) to create materials that simultaneously provide reactive sites for biochemical stimuli and maintain structural integrity. The copolymer architecture integrates different functional units within a single material system, resolving the contradiction between adaptability and complexity.
Solution Approach 2:
The spiro lactide units are incorporated at specific positions within the copolymer chain to provide localized reactive sites for biochemical stimuli. This allows the material to have regions with high reactivity for cell interaction while other regions maintain structural stability, effectively addressing the need for selective functionality without uniform complexity throughout the entire material.
2Adaptability or versatility
If synthetic biomaterials are designed to mimic ECM physical characteristics, then tissue regeneration support is improved, but the materials still lack biochemical cue presentation capability
Solution Approach 1:
The patent modifies the chemical structure parameters of the polymer by incorporating spiro lactide units with specific functional groups that provide biochemical reactivity. By adjusting the composition ratio of spiro lactide to other lactide monomers, the material achieves optimal balance between biochemical stimulus presentation and manufacturing feasibility, as the ring-opening polymerization process remains relatively straightforward despite the enhanced functionality.
3Adaptability or versatility
If copolymer composition is adjusted to increase reactive sites, then biochemical stimulus presentation improves, but mechanical properties may be compromised
Solution Approach 1:
The patent optimizes the compositional parameters of the copolymer by controlling the ratio of spiro lactide to other lactide monomers. This allows tuning of the material to achieve sufficient biochemical reactivity while maintaining adequate mechanical strength through the contribution of more stable polymer units in the copolymer structure.
Solution Approach 2:
The copolymer architecture acts as a composite at the molecular level, where spiro lactide units provide biochemical functionality and other lactide units provide structural support. This composite approach enables the material to simultaneously achieve both biochemical stimulus presentation and mechanical integrity without requiring separate components.
Data Source
AI summary
An example of a block or graft copolymer includes a random copolymer including a first monomer:and a second monomer; and i) a homopolymer including a third monomer, wherein the third monomer is any monomer other than the first monomer, or ii) a second random copolymer other than the random copolymer. The random copolymer can also be part of a star-shaped copolymer. Any of the copolymers may be incorporated into a composition or used as a coating on a medical device.